Paper16005263
Evasion of immune responses to introduced human acid alpha-glucosidase by liver-restricted expression in glycogen storage disease type II.
Franco LM and 11 others. Mol Ther, 2005. Cited by 164 papers, by iCite.
Cite this record
ConductScience Library. Evasion of immune responses to introduced human acid alpha-glucosidase by liver-restricted expression in glycogen storage disease type II. Papers, record 16005263. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16005263
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Creatine Kinase, MM Form | Major topic |
| Genetic Vectors | Major topic |
| Glycogen Storage Disease Type II | Major topic |
| Liver | Major topic |
| alpha-Glucosidases | Major topic |
| Animals | |
| Antibody Formation | |
| Creatine Kinase | |
| DNA, Viral | |
| Dependovirus | |
| Enhancer Elements, Genetic | |
| Gene Transfer Techniques | |
| Genetic Therapy | |
| Glycogen | |
| Humans | |
| Mice | |
| Mice, Knockout | |
| Muscle, Skeletal | |
| Plasmids | |
| Promoter Regions, Genetic |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01-DK 52925 | NIDDK NIH HHS | United States | R01DK052925 | PubMed and NIH |
Source NIH RePORTER
Cited by117
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 164 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42442016 | Neonatal gene therapy with AAV2/8-LSPhGAA improves hypertrophic cardiomyopathy in the Gaac.1826dupA knock-in murine model. | Mol Genet Metab | 2026 | https://conductscience.org/library/papers/42442016 | PubMed |
| 41491260 | Assessment of Immune Responses Against AAV Encoded Transgene Products. | AAPS J | 2026 | https://conductscience.org/library/papers/41491260 | PubMed |
| 41485391 | Novel promoters drive therapeutic transgene expression and evade transgene-specific immune responses in a mouse model of Pompe disease. | Mol Genet Metab | 2026 | https://conductscience.org/library/papers/41485391 | PubMed |
| 41442049 | New advances in treating late-onset Pompe Disease: A narrative review. | Eur J Pediatr | 2025 | https://conductscience.org/library/papers/41442049 | PubMed |
| 41223291 | Liver-directed AAV gene therapy in mice corrects glycogen storage disease type IX γ2. | Sci Adv | 2025 | https://conductscience.org/library/papers/41223291 | PubMed |
| 41167625 | Enhancing AAV9-UFμDys1 Gene Therapy Efficacy Through Immunosuppression in Mice with Pre-Existing Immunity and Enabling Redosing Strategies for Duchenne Muscular Dystrophy. | Hum Gene Ther | 2026 | https://conductscience.org/library/papers/41167625 | PubMed |
| 41059362 | Long-Term Correction of Murine Glycogen Storage Disease Type III by AAV-Mediated Gene Therapy Using an Immunotolerizing Dual Promoter to Express Bacterial Pullulanase. | Adv Cell Gene Ther | 2025 | https://conductscience.org/library/papers/41059362 | PubMed |
| 40927766 | A myotropic AAV vector combined with skeletal muscle cis-regulatory elements improve glycogen clearance in mouse models of Pompe disease. | Mol Ther Methods Clin Dev | 2025 | https://conductscience.org/library/papers/40927766 | PubMed |
| 40183436 | Management of Pompe disease alongside and beyond ERT: a narrative review. | Acta Myol | 2025 | https://conductscience.org/library/papers/40183436 | PubMed |
| 39838066 | Incomplete elimination of viral genomes is associated with chronic inflammation in nonhuman primate livers after AAV-mediated gene transfer. | Gene Ther | 2025 | https://conductscience.org/library/papers/39838066 | PubMed |
| 39687734 | Preclinical efficacy and safety of adeno-associated virus 5 alpha-galactosidase: A gene therapy for Fabry disease. | Mol Ther Methods Clin Dev | 2024 | https://conductscience.org/library/papers/39687734 | PubMed |
| 39277505 | Neurological glycogen storage diseases and emerging therapeutics. | Neurotherapeutics | 2024 | https://conductscience.org/library/papers/39277505 | PubMed |
| 39134822 | Advances in Pompe Disease Treatment: From Enzyme Replacement to Gene Therapy. | Mol Diagn Ther | 2024 | https://conductscience.org/library/papers/39134822 | PubMed |
| 38753465 | Synergism of dual AAV gene therapy and rapamycin rescues GSDIII phenotype in muscle and liver. | JCI Insight | 2024 | https://conductscience.org/library/papers/38753465 | PubMed |
| 38664313 | Advances in Immune Tolerance Induction in Enzyme Replacement Therapy. | Paediatr Drugs | 2024 | https://conductscience.org/library/papers/38664313 | PubMed |
| 38138129 | AAV Immunotoxicity: Implications in Anti-HBV Gene Therapy. | Microorganisms | 2023 | https://conductscience.org/library/papers/38138129 | PubMed |
| 37759679 | A Comprehensive Update on Late-Onset Pompe Disease. | Biomolecules | 2023 | https://conductscience.org/library/papers/37759679 | PubMed |
| 37701327 | Screening data from 19 patients with late-onset Pompe disease for a phase I clinical trial of AAV8 vector-mediated gene therapy. | JIMD Rep | 2023 | https://conductscience.org/library/papers/37701327 | PubMed |
| 37463048 | AAV-mediated delivery of secreted acid α-glucosidase with enhanced uptake corrects neuromuscular pathology in Pompe mice. | JCI Insight | 2023 | https://conductscience.org/library/papers/37463048 | PubMed |
| 37421310 | Gene therapy for glycogen storage diseases. | J Inherit Metab Dis | 2024 | https://conductscience.org/library/papers/37421310 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| GAA | 2548 | PubTator's text mining | https://conductscience.org/library/genes/2548 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16005263
GET https://conductscience.org/api/papers/v1/16005263/cited_by?page=2